TY - JOUR
T1 - Prevalence of Hidradenitis Suppurativa in the Netherlands
T2 - A Cross-Sectional Study as Part of the Global Hidradenitis Suppurativa Atlas (GHiSA)
AU - van Huijstee, Johanna C
AU - van Straalen, Kelsey R
AU - Bouazzi, Dorra
AU - Medianfar, Cecilia E
AU - Jemec, Gregor B E
AU - Christensen, Robin
AU - Aarts, Pim
AU - Mangal, Raveena A
AU - Erdal, Beyza
AU - Geraedts, Nienke C T
AU - Prens, Errol P
AU - van der Zee, Hessel H
N1 - © 2025 The Author(s). Published by S. Karger AG, Basel.
PY - 2025
Y1 - 2025
N2 - UNLABELLED: Introduction: The global prevalence of the chronic and debilitating skin disease hidradenitis suppurativa (HS) is currently unknown. Depending on the research type and the studied population, reported prevalence rates for HS range from 0.03% to 4.1%. It is crucial to investigate the global prevalence of HS using a standardized study design to facilitate earlier recognition, diagnosis, and treatment of patients. Consequently, a worldwide initiative, the Global Hidradenitis Suppurativa Atlas (GHiSA), has developed a study design to investigate the worldwide prevalence of HS in a comparable manner. In cooperation with this initiative, this study aimed to investigate the prevalence of HS in the Netherlands.METHODS: An explorative, descriptive, cross-sectional mono-center study was conducted at the Ear Nose Throat and Internal Medicine department of the Erasmus Medical Center. Healthy adults accompanying patients undergoing care in a hospital setting were asked to fill out a validated questionnaire and undergo physical examination. Primary outcome was the point prevalence of HS.RESULTS: In total, 663 participants were included in this study. Overall, the prevalence of HS was 0.60% (4/663, 95% confidence interval 0.32%-1.54%).CONCLUSION: The point prevalence of HS in the Netherlands is 0.60%. This study is part of a global initiative; therefore, data can be incorporated in a worldwide analysis of the HS prevalence. .
AB - UNLABELLED: Introduction: The global prevalence of the chronic and debilitating skin disease hidradenitis suppurativa (HS) is currently unknown. Depending on the research type and the studied population, reported prevalence rates for HS range from 0.03% to 4.1%. It is crucial to investigate the global prevalence of HS using a standardized study design to facilitate earlier recognition, diagnosis, and treatment of patients. Consequently, a worldwide initiative, the Global Hidradenitis Suppurativa Atlas (GHiSA), has developed a study design to investigate the worldwide prevalence of HS in a comparable manner. In cooperation with this initiative, this study aimed to investigate the prevalence of HS in the Netherlands.METHODS: An explorative, descriptive, cross-sectional mono-center study was conducted at the Ear Nose Throat and Internal Medicine department of the Erasmus Medical Center. Healthy adults accompanying patients undergoing care in a hospital setting were asked to fill out a validated questionnaire and undergo physical examination. Primary outcome was the point prevalence of HS.RESULTS: In total, 663 participants were included in this study. Overall, the prevalence of HS was 0.60% (4/663, 95% confidence interval 0.32%-1.54%).CONCLUSION: The point prevalence of HS in the Netherlands is 0.60%. This study is part of a global initiative; therefore, data can be incorporated in a worldwide analysis of the HS prevalence. .
KW - Acne inversa
KW - Cross-sectional study
KW - GHiSA
KW - Hidradenitis suppurativa
KW - Prevalence
KW - Cross-Sectional Studies
KW - Humans
KW - Middle Aged
KW - Hidradenitis Suppurativa/epidemiology
KW - Male
KW - Young Adult
KW - Adolescent
KW - Adult
KW - Female
KW - Aged
KW - Netherlands/epidemiology
U2 - 10.1159/000542816
DO - 10.1159/000542816
M3 - Article
C2 - 40623395
SN - 1018-8665
VL - 241
SP - 139
EP - 144
JO - Dermatology
JF - Dermatology
IS - Suppl. 1
ER -